1. Japan Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Ohki Health Care Holdings, Inc.

Ohki Health Care Holdings, Inc.

TTSE:3417
970.00
JPY
+3.00
(+0.31%)
18.16BMarket Cap
Nov 11Next Earn
Ohki Health Care Holdings, Inc.
TSE:3417
(Tokyo Stock Exchange)

Recent

price

970.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
12,583.61
12,987.53
14,003.39
16,110.29
13,626.7
15,065.03
15,917.23
17,085.05
18,475.56
19,999.81
19,644.25
20,169.01
22,074.79
24,293.96
25,617.06
26,416.6
- -
Revenue per Share
78.68
46.97
50.98
84.66
22.57
53.85
54.34
164.98
146.53
170.67
199.4
70.48
158.21
160.43
193.46
98.16
- -
Basic EPS, GAAP
93.17
175.31
5.83
-136.29
-57.41
76.63
-59.42
374.68
165.04
-97.74
-321.43
84.47
-16.17
524.7
-891.63
-205.99
- -
Free Cash Flow per Basic Share
6.99
9.99
9.91
10.38
10.96
10.96
11.88
12.98
16.87
18.03
18.85
19.87
21.17
22.07
23.97
25.88
- -
Dividend per Share
554.96
636.85
760.81
772.38
827.92
892.86
981.9
1,190.3
1,251.08
1,392.65
1,590.39
1,591.27
1,749.26
2,040.56
2,271.62
2,504.16
- -
Book Value per Share
537.81
620.77
740.4
754.1
812.47
879.82
971.35
1,182.58
1,245.01
1,385.98
1,583.65
1,583
1,737.01
2,028.68
2,253
2,485.54
- -
Tangible Book Value per Share
12
12
12
12
14
14
14
14
14
14
14
14
14
14
14
14
14
Basic Weighted Avg Shares
151,141
155,941
168,102
186,292
187,765
207,593
222,342
239,531
258,481
277,260
270,927
278,162
304,445
334,661
349,452
360,358
- -
Sales/Revenue/Turnover
1.71
1.39
1.36
1.34
0.77
1.06
0.59
0.98
0.79
0.81
1.09
0.23
0.68
0.61
0.79
0.2
- -
Operating Margin (%)
272
312
264
326
393
383
356
366
371
401
396
381
375
377
387
450
- -
Depreciation Expense
945
564
612
979
311
742
759
2,313
2,050
2,366
2,750
972
2,182
2,210
2,639
1,339
- -
Net Income, GAAP
44.59
46.88
52.56
36.61
51.03
55.25
43.65
28.31
31.77
26.92
29.88
39.52
31.36
37.53
31
42.37
- -
Effective Tax Rate (%)
0.63
0.36
0.36
0.53
0.17
0.36
0.34
0.97
0.79
0.85
1.02
0.35
0.72
0.66
0.76
0.37
- -
Profit Margin (%)
133
10
-830
130
1,345
1,883
1,749
1,003
2,694
4,236
7,127
8,060
10,350
12,421
13,920
15,302
- -
Working Capital
2,408
1,904
1,233
1,111
2,164
1,988
1,285
444
422
258
250
300
1,845
1,524
3,087
2,527
- -
LT Debt
6,699
7,680
9,198
10,701
11,409
12,401
13,778
16,663
17,541
19,312
22,136
22,091
24,271
27,897
31,052
34,164
- -
Total Equity
4.51
2.46
2.24
3.61
-0.53
1.32
3.31
7.1
5.72
6.57
7.19
1.24
4.46
3.69
4.67
0.86
- -
Return on Invested Capital (%)
7.61
4.45
4.38
6.16
1.96
4.07
3.67
10.16
8.62
9.5
9.58
3.45
7.07
6.85
6.7
3.12
- -
Return on Capital (%)
16.33
7.88
7.3
9.9
2.82
6.24
5.8
15.2
12
12.89
13.37
4.43
9.47
8.51
8.97
4.11
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
10,078
13,096
- -
LT Borrowings
2,792
2,527
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
18,866
18,157
15,360

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
121,126
122,836
- -
Cash, Cash Equivalents & STI
3,185
2,213
- -
Accounts Receivable, Net
76,544
75,641
- -
Inventories
29,789
32,684
- -
Total Current Liabilities
106,339
107,534
- -
Payables & Accruals
- -
- -
- -
ST Debt
10,078
13,096
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.8%
9.19%
10.02%
Free Cash Flow
-483.09%
-786.37%
-76.9%
Net Income, GAAP
25.86%
6.25%
-49.26%
Sales/Revenue/Turnover
5.73%
5.92%
3.12%
Total Cash Common Dividend
9.08%
6.32%
7.95%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
349,452
2026
- -
- -
- -
- -
360,358
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
193.46
2026
- -
- -
- -
- -
98.16
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
23.97
2026
- -
- -
- -
- -
25.88
2027
- -
- -
- -
- -
- -
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Ohki Healthcare Holdings Co., Ltd. is a Japan-based holding company primarily engaged in the wholesale distribution and production of pharmaceutical products, health foods, and related consumer goods through its subsidiaries. Founded in 1658 and headquartered in Bunkyo-ku, Tokyo, the company offers a broad portfolio of products including pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and deleterious substances, health foods, nursing care products, oral care items, baby products, daily necessities, clothing, confectionery, foodstuffs, food additives, alcoholic beverages, pet supplies, feed additives, sanitary products, beauty and health equipment, sporting goods, leisure goods, toys, stationery, household goods, chemicals, fertilizers, pesticides, gardening supplies, and agricultural products; it also provides warehousing, information processing systems, distribution equipment, software development, pharmacy management, dispensing services, nursing services, and license application agency services primarily targeting household, catering, supermarkets, department stores, and pharmacies in Japan with international operations in China and Vietnam. The company operates in the pharmaceuticals and medical research sector, focusing on generic pharmaceuticals and healthcare distribution. In June 2024, Ohki Healthcare Holdings invested in ONE-INCH Ltd. as part of a funding round, marking a recent strategic investment in external growth opportunities.